Found: 9
Select item for more details and to access through your institution.
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 56, doi. 10.1159/000531024
- By:
- Publication type:
- Article
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182
- By:
- Publication type:
- Article
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 70, doi. 10.1159/000531176
- By:
- Publication type:
- Article
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 99, doi. 10.1159/000531377
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 1, doi. 10.1159/000537766
- Publication type:
- Article
Objective Response to Systemic Therapy Is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 1, doi. 10.1159/000535516
- By:
- Publication type:
- Article
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 6, doi. 10.1159/000530700
- By:
- Publication type:
- Article
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 29, doi. 10.1159/000530950
- By:
- Publication type:
- Article
HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 41, doi. 10.1159/000530699
- By:
- Publication type:
- Article